| Literature DB >> 35089250 |
Hyoung Ook Kim1, Byung Chan Lee1, Chan Park1, Jae Kyu Kim1, Won-Ju Park2, Jong Eun Lee1, Hyo Soon Lim1, Won Gi Jeong1.
Abstract
ABSTRACT: Transarterial chemoembolization is the standard treatment option for intermediate-stage hepatocellular carcinoma (HCC). However, during the interventional procedure, occupational radiation protection is compromised. The use of real-time radiation dosimetry could provide instantaneous radiation doses. This study aimed to evaluate the occupational dose of the medical staff using a real-time radiation dosimeter during transarterial chemoembolization (TACE) for HCC, and to investigate factors affecting the radiation exposure dose.This retrospective observational study included 70 patients (mean age: 66 years; age range: 38-88 years; male: female = 59: 11) who underwent TACE using real-time radiation dosimetry systems between August 2018 and February 2019. Radiation exposure doses of operators, assistants, and technicians were evaluated. Patients' clinical, imaging, and procedural information was analyzed.The mean dose-area product (DAP) and fluoroscopy time during TACE were 66.72 ± 55.14 Gycm2 and 12.03 ± 5.95 minutes, respectively. The mean radiation exposure doses were 24.8 ± 19.5, 2.0 ± 2.2, and 1.65 ± 2.0 μSv for operators, assistants, and technicians, respectively. The radiation exposure of the operators was significantly higher than that of the assistants or technicians (P < .001). The perpendicular position of the adjustable upper-body lead protector (AULP) on the table was one factor reducing in the radiation exposure of the assistants (P < .001) and technicians (P = .040). The DAP was a risk factor for the radiation exposure of the operators (P = .003) and technicians (P < .001).Occupational doses during TACE are affected by DAP and AULP positioning. Placing the AULP in the perpendicular position during fluoroscopy could be a simple and effective way to reduce the radiation exposure of the staff. As the occupational dose influencing factors vary by region or institution, further study is needed.Entities:
Mesh:
Year: 2022 PMID: 35089250 PMCID: PMC8797565 DOI: 10.1097/MD.0000000000028744
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.889
Figure 1Positions of the staff and the adjustable upper-body lead protector. (1) parallel position to the table; (2) perpendicular position to the table; A = assistant; C = controller; D = detector; LP = Adjustable upper-body lead protector; M = monitor; O = operator; RT = radiology technician; T = table.
Figure 2Radiation dosimeter badge-wearing sites for the staff.
Baseline characteristics of patients and factors affecting radiation exposure.
| Baseline characteristics | |
| Age | 66.86 ± 11.30 |
| Male sex | 59 (84.29%) |
| BMI, kg/m2 | 24.59 ± 3.89 |
| DM | 38 (54.29%) |
| HTN | 24 (34.29%) |
| Creatine | 1.33 ± 1.21 |
| AFP | 166.24 ± 576.78 |
| Child–Pugh class | |
| A | 56 (80%) |
| B | 14 (20%) |
| Number of tumors | 2.14 ± 1.52 |
| Extrahepatic collaterals | 12 (17.14%) |
| Operator | |
| 1 | 23 (32.86%) |
| 2 | 47 (67.14%) |
| Selected feeder number | 2.03 ± 1.22 |
| Position of AULP to table | |
| Vertical | 25 (35.71%) |
| Horizontal | 45 (64.29%) |
| Procedure time, min | 30.81 ± 11.78 |
| Fluoroscopic time, min | 12.03 ± 5.95 |
| Number of DSA | 9.69 ± 3.07 |
| Total DAP, Gycm2 | 66.72 ± 55.14 |
| Cumulative Air-kerma, mGy | 205.20 ± 161.61 |
AFP = alpha fetoprotein, AULP = adjustable upper-body lead protector, BMI = body mass index, DAP = dose–area product, DM = diabetes mellitus, DSA = digital subtraction angiography, HTN = hypertension.
Figure 3Correlation of the dose–area product with the cumulative air kerma (A), body mass index (B), fluoroscopic time (C), and digital subtraction angiography number (D). DAP = dose–area product.
Figure 4Occupational doses of operators, assistants, and technicians.
Univariate linear regression of radiation exposure doses of each subgroup and variable.
| Variables | Operator Coef (95% CI) |
| Assistant Coef (95% CI) |
| Technician Coef (95% CI) |
|
| Age | 0.083 (−0.339–0.505) | .697 | −0.046 (−0.093–0.001) | .053 | −0.005 (−0.047–0.037) | .804 |
| Male | −17.193 (−35.192–0.821) | .068 | −0.324 (−1.801–1.152) | .545 | −1.267 (−2.553–0.021) | .058 |
| Obesity | 5.023 (−4.535–14.581) | .298 | 1.666 (0.647–2.684) | .001 | 0.541 (−0.412–1.493) | .262 |
| DM | 2.472 (−7.057–12.002) | .606 | 0.874 (−0.190–1.938) | .106 | 0.517 (−0.427–1.461) | .278 |
| HTN | 3.644 (−6.289–13.577) | .732 | 0.261 (−0.886–1.407) | .651 | 0.725 (−0.256–1.706) | .145 |
| Creatine | −0.536 (−4.450–3.378) | .785 | 0.091 (−0.356–0.537) | .687 | −0.184 (−0.574–0.205) | .349 |
| AFP | −0.002 (−0.010–0.007) | .393 | −0.000 (−0.001–0.001) | .924 | −0.001 (−0.001–0.000) | .166 |
| Child–Pugh class | −1.483 (−6.988–4.022) | .593 | −0.127 (−0.732–0.478) | .677 | −0.175 (−0.727–0.376) | .528 |
| Number of tumors | 0.236 (−2.905–3.377) | .881 | −0.191 (−0.546–0.165) | .288 | −0.236 (−0.546–0.073) | .132 |
| EHC | −1.893 (−14.387–10.601) | .763 | 1.009 (−0.398–2.416) | .157 | 0.421 (−0.828–1.670) | .503 |
| Operator | −3.254 (−13.288–6.797) | .521 | −1.043 (−2.163–0.076) | .067 | −0.937 (−2.971–1.112) | .356 |
| Feeder number | 1.195 (−2.707–5.098) | .543 | −0.112 (−0.566–0.341) | .597 | −0.148 (−0.539–0.243) | .452 |
| Position of AULP | −11.049 (−20.646–2.452) | .025 | −2.492 (−3.452–−1.531) | < .001 | −1.047 (−2.002–−0.093) | .032 |
| Fluoroscopic time | 1.799 (0.969–2.630) | < .001 | 0.125 (0.039–0.212) | .005 | 0.080 (−0.003–0.163) | .058 |
| Number of DSA | 2.535 (1.017–4.053) | .001 | −0.017 (−0.194–0.160) | .848 | 1.112 (−0.050–0.274) | .172 |
| Total DAP | 0.298 (0.183–0.414) | < .001 | 0.015 (0.006–0.025) | .001 | 0.033 (0.022–0.044) | < .001 |
| CumuAir-kerma | 0.111 (0.071–0.151) | < .001 | 0.004 (0.001–0.007) | .009 | 0.011 (0.007–0.015) | < .001 |
AFP = alpha fetoprotein, AULP = adjustable upper-body lead protector, BMI = body mass index, CI = confidence interval, Coef = coefficient, DAP = dose–area product, DM = diabetes mellitus, DSA = digital subtraction angiography, EHC = extrahepatic collateral, HTN = hypertension.
Figure 5Radiation exposure dose for operators (A), assistants (B), and technicians (C) according to the adjustable upper-body lead protector position. AULP = adjustable upper-body lead protector.
Multivariate linear regression of each occupational dose and the variables.
| Variables | Operator Coef (95% CI) |
| Assistant Coef (95% CI) |
| Technician Coef (95% CI) |
|
| Obesity | −2.223 (−12.418–7.971) | .664 | 0.941 (−0.090–1.972) | .073 | −0.624 (−1.558–0.309) | .186 |
| Position of AULP | −.6.677 (−15.210–1.856) | .123 | −2.139 (−3.072–−1.205) | < .001 | −0.821 (−1.602–0.040) | .040 |
| Fluoroscopic time | 0.719 (−0.222–1.660) | .132 | 0.055 (−0.036–0.146) | .233 | −0.027 (−0.103–0.048) | .471 |
| Number of DSA | 1.092 (−0.478–2.661) | .430 | 0.008 (−0.136–0.152) | .912 | 0.014 (0.127–0.155) | .845 |
| Total DAP | 0.239 (0.082–0.395) | .003 | 0.010 (0.005–0.021) | .068 | 0.031 (0.017–0.045) | < .001 |
AULP = adjustable upper-body lead protector, BMI = body mass index, CI = confidence interval, DAP = dose–area product, DSA = digital subtraction angiography.